INTRODUCTION: The normal cranial nerves (CNs) of the cavernous sinus can be clearly demonstrated using contrast-enhanced constructive interference in steady-state (CISS) magnetic resonance imaging (MRI). This study used the method to evaluate pathological CNs III, IV, V(1), V(2), and VI in cavernous sinuses affected by inflammatory and neoplastic diseases. METHODS: MR images from 17 patients with diseases involving the cavernous sinuses and/or causing neuropathy in CNs III-VI were retrospectively evaluated. The patients were divided into inflammatory (n=11) and neoplastic (n=6) groups. We defined CNs as abnormal when they exhibited enlargement or enhancement. CNs were evaluated using both contrast-enhanced CISS and T1-weighted MRI. RESULTS: In the inflammatory group, abnormal CNs were identified by contrast-enhanced CISS MRI in 13 of 25 symptomatic CNs (52%) in eight patients, but in only two CNs (8%) in two patients by contrast-enhanced T1-weighted MRI. In the neoplastic group, both sequences of contrast-enhanced CISS and T1-weighted MRI detected abnormalities in the same three of eight symptomatic CNs (37.5%), i.e., the three CNs were all in the same patient with adenoid cystic carcinoma. CONCLUSION: Contrast-enhanced CISS MRI is useful for detecting CN abnormalities in inflammatory pathological conditions of the cavernous sinuses.
INTRODUCTION: The normal cranial nerves (CNs) of the cavernous sinus can be clearly demonstrated using contrast-enhanced constructive interference in steady-state (CISS) magnetic resonance imaging (MRI). This study used the method to evaluate pathological CNs III, IV, V(1), V(2), and VI in cavernous sinuses affected by inflammatory and neoplastic diseases. METHODS: MR images from 17 patients with diseases involving the cavernous sinuses and/or causing neuropathy in CNs III-VI were retrospectively evaluated. The patients were divided into inflammatory (n=11) and neoplastic (n=6) groups. We defined CNs as abnormal when they exhibited enlargement or enhancement. CNs were evaluated using both contrast-enhanced CISS and T1-weighted MRI. RESULTS: In the inflammatory group, abnormal CNs were identified by contrast-enhanced CISS MRI in 13 of 25 symptomatic CNs (52%) in eight patients, but in only two CNs (8%) in two patients by contrast-enhanced T1-weighted MRI. In the neoplastic group, both sequences of contrast-enhanced CISS and T1-weighted MRI detected abnormalities in the same three of eight symptomatic CNs (37.5%), i.e., the three CNs were all in the same patient with adenoid cystic carcinoma. CONCLUSION: Contrast-enhanced CISS MRI is useful for detecting CN abnormalities in inflammatory pathological conditions of the cavernous sinuses.
Authors: Y Shigematsu; Y Korogi; T Hirai; T Okuda; I Ikushima; T Sugahara; L Liang; M Takahashi Journal: J Comput Assist Tomogr Date: 1999 Mar-Apr Impact factor: 1.826
Authors: D M Yousem; S W Atlas; R I Grossman; R C Sergott; P J Savino; T M Bosley Journal: AJNR Am J Neuroradiol Date: 1989 Nov-Dec Impact factor: 3.825
Authors: Thomas F Barrett; Hadrien A Dyvorne; Francesco Padormo; Puneet S Pawha; Bradley N Delman; Raj K Shrivastava; Priti Balchandani Journal: World Neurosurg Date: 2017-03-27 Impact factor: 2.104
Authors: G Conte; F Di Berardino; C Sina; D Zanetti; E Scola; C Gavagna; L Gaini; G Palumbo; P Capaccio; F Triulzi Journal: AJNR Am J Neuroradiol Date: 2017-05-25 Impact factor: 3.825
Authors: Sung Jun Ahn; Mi Ri Yoo; Sang Hyun Suh; Seung-Koo Lee; Kyu Sung Lee; Eun Jin Son; Tae-Sub Chung Journal: PLoS One Date: 2014-07-22 Impact factor: 3.240